Ketamine for Depression—Knowns, Unknowns, Possibilities, Barriers, and Opportunities
Author:
Affiliation:
1. Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India
Abstract
Publisher
American Medical Association (AMA)
Subject
Psychiatry and Mental health
Link
https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2811308/jamapsychiatry_andrade_2023_vp_230033_1700673888.27356.pdf
Reference9 articles.
1. A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009-January 2019.;Marcantoni;J Affect Disord,2020
2. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: a systematic review and meta-analysis.;Xiong;J Psychiatr Res,2021
3. Ketamine versus ECT for nonpsychotic treatment-resistant major depression.;Anand;N Engl J Med,2023
4. Efficacy and safety of ketamine vs electroconvulsive therapy among patients with major depressive episode: a systematic review and meta-analysis.;Rhee;JAMA Psychiatry,2022
5. Racemic ketamine as an alternative to electroconvulsive therapy for unipolar depression: a randomized, open-label, non-inferiority trial (KetECT).;Ekstrand;Int J Neuropsychopharmacol,2022
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A randomised, open-label, pragmatic pilot comparison of oral and intravenous ketamine in treatment-resistant depression;Asian Journal of Psychiatry;2024-09
2. At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data;Journal of Affective Disorders;2024-09
3. Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions;Journal of Anesthesia and Translational Medicine;2024-09
4. Repeated dosing with oral racemic ketamine as a successful rescue intervention for coping with life events in recurrent major depressive disorder;Asian Journal of Psychiatry;2024-04
5. Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?;European Archives of Psychiatry and Clinical Neuroscience;2024-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3